ENStage 4 prostate cancer treatment in Germany is long-term drug therapy that suppresses testosterone, plus radiotherapy and bone protection as needed. Stage 4 means spread beyond the prostate, to lymph nodes or distant organs, mostly bone. With distant metastases a cure is usually impossible, but in many men progression can be slowed for a long time, and German uro-oncologists say so plainly.
Below: what treatment involves and why the first step is to establish how far it has spread. General information: prostate cancer treatment in Germany.
What is established before treatment starts
Before treatment, doctors establish the spread, aggressiveness and genetic changes of the cancer and the state of bones and kidneys. PSMA-PET/CT, whose weakly radioactive tracer binds to prostate cancer cells, shows metastases more accurately than CT plus bone scan; the German S3 guideline calls for it when distant spread is likely, which can change stage and plan.
Also needed: PSA trend, testosterone, a Gleason score from reviewed slides and metastatic volume, few deposits or many, still judged on CT and bone scan. «Grade 4» in everyday speech means stage 4, but the ISUP grade on a pathology report describes how aggressive the cells are. N1 and M1 are explained by the Cancer Information Service of the German Cancer Research Center.
Men with metastases should be offered genetic counselling and a blood test for inherited changes; before treating the castration-resistant phase, tumour tissue is tested too. BRCA1, BRCA2 and other DNA repair gene changes guide drug choice, and inherited ones matter for relatives. More on prostate cancer diagnostics in Germany.
Hormone blockade as the backbone
Hormone blockade is the backbone because prostate cancer grows on testosterone. Usually it is a depot injection that lasts one, two, three or six months depending on the product; daily tablets and irreversible removal of the testicles are alternatives.
What has changed: for men in good general condition, blockade alone is no longer enough. The guideline advises adding, within the first months, a modern antiandrogen (apalutamide, darolutamide, enzalutamide) or abiraterone, which blocks androgen production; men fit for chemotherapy may also be offered docetaxel. The choice depends on metastatic volume, fitness and other illnesses; blockade alone is for men unsuited to a combination.
Side effects are explained early: hot flushes, loss of libido and erections, muscle loss, fat gain, mood changes, thinning bones, and higher risk of heart disease and diabetes. The guideline advises exercise for muscle and fat, calcium and vitamin D for bones, medication for confirmed osteoporosis; drugs can ease severe flushes. More on hormone therapy in oncology in Germany.
When blockade stops being enough
When blockade stops being enough, it continues and the next treatment is added. In this castration-resistant phase PSA rises on several tests in a row, or new deposits appear, despite suppressed testosterone. The disease is not curable now, but this is the next line, not the end of treatment.
Without prior new-generation hormone drugs, the options are abiraterone, enzalutamide or docetaxel; after docetaxel and such a drug, cabazitaxel or lutetium-177-PSMA radioligand therapy, EU-approved for deposits that take up the PSMA-PET tracer. BRCA1 or BRCA2 changes call for the PARP inhibitor olaparib alone or a PARP inhibitor plus a hormone drug. Switching hormone drugs rarely helps after a short response. The guideline wants the next step chosen by a tumour board, not one doctor.
Docetaxel and cabazitaxel are given as a drip, usually once every three weeks, with blood checks and treatment of side effects between doses. Lutetium-177-PSMA is given in nuclear medicine every six weeks, up to six doses in total. More on chemotherapy for prostate cancer in Germany.
Bone, pain and radiotherapy
Bone is the commonest site of metastases, causing pain, fractures and risk of spinal cord compression, so pain relief, radiotherapy and bone protection accompany the main treatment. The guideline advises bone-protecting drugs for these metastases once castration-resistant, earlier only for osteoporosis, with calcium and vitamin D; a dental check, with treatment if needed, precedes the first dose to help prevent osteonecrosis, the death of jawbone tissue.
Radiotherapy treats a bone deposit causing persistent pain or threatening fracture or cord compression, the latter urgently. In newly diagnosed disease with few metastases, the guideline also allows radiotherapy to the prostate. Pain relief is a full treatment goal, not an afterthought: painkillers are adjusted with the main therapy and palliative care is discussed early.
Monitoring and living through treatment
PSA, blood and well-being are checked every few months. Scans come at the start and at the lowest PSA, then less often while stable, more often once castration-resistant, and in between for new pain or rising PSA. The regimen works if PSA falls and stays low, deposits stop growing and pain eases.
Besides drugs, appointments cover exercise, advised by the guideline for everyone in cancer treatment, a diet rich in plant foods, fatigue, intimacy, mood and talking with family. More on advanced prostate cancer treatment in Germany.
Frequently asked questions
Can stage 4 prostate cancer be cured?
With metastases in bones or other organs, a cure is usually impossible, though in many men progression can be slowed for a long time. If only lymph nodes near the prostate are affected, radiotherapy to the prostate and pelvic nodes, or surgery, is added to hormone therapy.
How long does hormone therapy last at stage 4?
Usually throughout treatment: blockade continues even in the castration-resistant phase. New-generation drugs added to it are taken while they work and are tolerated, and stopped at the patient’s wish, on progression or for intolerable side effects; if one drug of a combination is dropped for side effects, the rest continue.
What if hormone therapy has already started at home?
Do not stop it on your own; send documents early: injection schedule, dated PSA results, scans and histology. Doctors in Germany will judge whether to add a new-generation drug, possibly with chemotherapy, which the guideline advises within the first months of blockade. Missing tests are done during the visit.
How AlenMed arranges treatment in Germany
AlenMed collects slides, reports and imaging, has them translated and puts them before a uro-oncologist; the patient gets the tumour board’s conclusion, a written estimate, a date and a visa invitation, with an interpreter at appointments.
Settled in advance: how many days the PSMA-PET work-up takes, which injections and tablets continue at home between visits, and how PSA results reach the German doctor. Costs: see the cost of prostate cancer treatment in Germany.
This material is for information only and is not an offer. Treatment is decided by a doctor at an in-person consultation.
News on this topic
Charité treats first beta-thalassemia patient with CRISPR
At Berlin Charité, a 19-year-old beta-thalassemia patient became the first in Germany to receive the newly approved CRISPR gene therapy Exagamglogene Autotemcel.
Real-World Breast Cancer Study Confirms High Five-Year Survival Rates in Germany
A landmark study of over 43,000 German patients reveals a five-year invasive disease-free survival rate of 82.9 percent in early hormone receptor-positive breast cancer.
FDA Approves Jülich Diagnostic Radiotracer FET for Brain Tumor Imaging
The FDA approves the diagnostic radiotracer FET (Pixclara®) for evaluating brain gliomas, highlighting decades of neuro-oncology research at Forschungszentrum Jülich.
